Summary
Newborn Syrian hamsters (Mesocricatus auratus) were inoculated subcutaneously at birth with adenovirus-12, Hollinshead strain, and 4–5 days later they were treated with clam (M. mercenaria) liver extracts (CLE). The animals were segregated according to sex at 3 weeks of age. The tumor incidence in the males, both treated and controls, was statistically lower than in the corresponding females. The treated hamsters, both males and females, developed significantly fewer tumors than the corresponding controls. During the course of study the virus lost much of its oncogenicity but all animals inoculated with either the virulent or attenuated virus responded to treatments. The CLE in a total dose of 100–350 mcg per hamster given in 2–3 subcutaneous injections within 12 days after birth was effective in protecting some of the hamsters from developing tumors during the later part of their life. The common antitumor drug, methotrexate (MTX), also showed some inhibitory activity, at least in the male hamsters. The over-all results of 11 assay experiments, using 663 hamsters, carried out in our laboratory during the past several years showed that treatment with clam extracts reduced the tumor incidence by 50% or more as compared to the controls.
Similar content being viewed by others
References
Baron, S., H. Dubuy, C. E. Bucker, M. C. Johnson, J. Park, J. Billian, P. S. Sarma, andR. J. Huebner: Induction of interferon and viral resistance in animals by polymicleotides. Ann. N.Y. Acad. Sci.137, Art. 1, 568–581 (1970).
Berenblum, I.: The modifying influence of dichloroethylsulphide on the induction of tumors in mice by tar. J. Path. Bact.32, 425–434 (1929).
Berenblum, I.: The anti-carcinogenic action of dichlorodiethylsulphide (mustard gas). J. Path. Bact.34, 731–746 (1931).
Berenblum, I.: Experimental inhibition of tumor induction by mustard gas and other compounds. J. Path. Bact.40, 549–558 (1935).
Bertino, J. R.: The mechanism of action of the folate antagonists in man. Cancer Res.23, 1286–1306 (1963).
Bliznakov, E. G.: Effect of reticuloendothelial system stimulation on resistance to Rous sarcoma infection in chicken. Int. J. Cancer3, 336–343 (1968).
Chu, E. W., andR. A. Malmgren: An inhibitory effect of vitamin A on the induction of tumors of forestomach and cervix in the Syrian hamsters by carcinogenic polycyclic hydrocarbons. Cancer Res.25, 884–895 (1965).
Crabtree, H. G.: Retardation of rate of tumor induction by substances which inhibit glycolysis. J. Path. Bact.51, 303–309 (1940).
Crabtree, H. G.: Anti-carcinogenesis. Brit. med. Bull4, 345–348 (1946).
Eddy, B. E., G. E. Grubbs, andR. D. Young: Tumor immunity in hamsters infected with adenovirus type 12 or simian virus 40. Proc. Soc. exp. Biol. (N.Y.)117, 575–579 (1964).
Eddy, B. E., R. D.Young, and G. E.Grubbs: Protective efficacy of live attenuated adenovirus type 12 vaccine. Tenth International Congress for Microbiology Mexico, 1970, p. 179, Abstract Je-9.
Gelboin, H. V., andM. Klein: Skin tumorigenesis by 7,12-dimethyl-benz-anthracene: Inhibition by actinomycin D. Science145, 1321–1322 (1964).
Gelboin, H. V., M. Klein, andR. R. Bates: Inhibition of mouse skin tumorigenesis by actinomycin D. Proc. nat. Acad. Sci (Wash.)53, 1353–1360 (1965).
Haase, A. T., J. A. Kasel, andL. N. Chessin: Adenovirus type 12 oncogenicity in newborn hamsters: The effect of pokeweed mitogen. J. Immunol.101, 806–807 (1968).
Hennings, H., andR. K. Boutwell: On the mechanism of inhibition of benign and malignant skin tumor formation by actinomycin D. Life Sci.6, 173–181 (1967).
Hook, R. R., Jr., andB. E. Kirk: Sex resistance in weanling Syrian hamsters to adenovirus type 12-induced tumor transplantation. Proc. Amer. Ass. Cancer Res.7, 32 (1966).
Huebner, R. J., W. T. Lane, A. D. Welch, P. Galabresi, R. W. McCollum, andW. H. Prusoff: Inhibition by 5-iododeoxyuridine of the oncogenic effects of adenovirus type 12 in hamsters. Science142, 488–490 (1963).
Huebner, R. J., andG. J. Todaro: Oncogenesis of RNA tumor viruses as determinants of cancer. Proc. nat. Acad. Sci. (Wash.)64, 1087–1094 (1969).
Huebner, R. J.: Inherited “switch-off”: RNA tumor virus oncogenesis as determinants of cancer. U.I.C.C. Bull7, (No. 4), 1–2 (1969).
Judge, J. R.: Inhibition of effects of leukogenic viruses in mice by extracts ofMercenaria mercenaria. Proc. Soc. exp. Biol. (N.Y.)123, 299–320 (1966).
Judge, J. R.: Effect of thiamine deprivation on Friend virus leukemia in mice. Proc. Soc. exp. Biol. (N.Y.)128, 98–103 (1968).
Kirschstein, R. L., K. O. Smith, andE. A. Peters: Inhibition of adenovirus 12 oncogenicity by adeno-associated virus. Proc. Soc. exp. Biol. (N.Y.)128, 670–673 (1968).
Lappe, M. A., andB. P. Blair: Interference with mammary tumorigenesis by antilymphocytic serum. Proc. Amer. Ass. Cancer Res.11, 47 (1970).
Levy, H. G., L. W. Law, andA. S. Rabson: Inhibition of tumor growth by polyinosinic-polycytidylic acid. Proc. Soc. nat. Acad. Sci (Wash.)62, 351–361 (1969).
Li, C. P., B. Prescott, B. Eddy, G. Caldes, W. R. Green, E. C. Martino, andA. M. Young: Antiviral activity of paolins from clams. Ann. N.Y. Acad. Sci.130, 1, 374–382 (1965).
Li, C. P., O. C. Liu, B. Prescott, andE. C. Martino: Antineoplastic activity of clam liver extract. Nature (Lond.)219, 1163–1164 (1968).
Li, C. P., B. Prescott, B. E. Eddy, E. W. Chu, andE. C. Martino: Studies on inhibition of viral oncogenesis. I. Reduced tumor incidence in hamsters inoculated with adenovirus-12 and treated with clam extracts. J. nat. Cancer Inst.41, 1249–1253 (1968).
Li, C. P., W. G. Jahnes, andN. M. Tauraso: Studies on inhibition of viral oncogenesis. II. Inhibitory effect of L-asparaginase, clam liver extract and methotrexate on Rous sarcoma virus focus formation. Arch. ges. Virusforsch.32, 236–243 (1970).
McFarlane, E. S., andJ. A. Embil, Jr.: Effect of splenectomy and sex in hamsters on adenovirus-12 oncogenesis. Canad. J. Microbiol.12, 1285–1286 (1966).
Peries, J., J. C. Chuat, M. Canivet, andM. Boiron: Inhibition of adenovirus 12 oncogenicity in hamsters by simultaneous inoculation with adenovirus 5. Nature (Lond.)209, 738–739 (1966).
Raven, R. W.: Recent concepts of cancer prevention. Progr. exp. Tumor Res.10, 133–162 (1968).
Sarma, P. S., G. Shin, R. H. Neubauer: Virus induced sarcoma of mice: Inhibition of a synthetic polyribonucleotide complex. Proc. nat. Acad. Sci (Wash.)62, 1046–1051 (1969).
Sarma, P. S., S. Baron, andR. J. Huebner: Inhibitory effect of a synthetic interferon inducer on murine sarcoma and leukemia virus infectionin vitro. Nature (Lond.)224, 604–605 (1969).
Schmeer, M. R.: Growth-inhibiting agents from Mercenaria extracts. Chemical and biological properties. Science144, 413–414 (1964).
Toolan, H. W., andN. Ledinkio: Inhibition by H-1 virus of the incidence of tumors produced by adenovirus 12 in hamsters. Virology35, 475–478 (1968).
Van Duuren, B. L., A. Sivak, C. Katz, andS. Melchionne: Inhibition of tumor induction in two stage carcinogenesis on mouse skin. Cancer Res.29, 947–952 (1969).
Van Duuren, B. L., andS. Melchionne: Inhibition of tumorigenesis. Progr. exp. Tumor Res.12, 55–94 (1969).
Wattenberg, L. W.: Chemoprophylaxis of carcinogenesis: A review. Cancer Res.26, 1520–1526 (1966).
Yohn, D. S., C. A. Funk, V. I. Kalnins, andJ. T. Grace, Jr.: Sex-related resistance to adenovirus-12 oncogenesis. Influence of thymectomy at three weeks of age. J. nat. Cancer Inst.35, 617–624 (1965).
Yohn, D. S., C. A. Funk, andJ. T. Grace, Jr.: Sex-related resistance in hamsters to adenovirus-12 oncogenesis. II. Influence of virus dose. J. Virol.1, 1186–1192 (1967).
Yohn, D. S., C. A. Funk, andJ. T. Grace, Jr.: Sex-related resistance in hamsters to adenovirus-12 oncogenesis. III. Influence of immunologic impairment by thymectomy or cortisone. J. Immunol.100, 771–780 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Li, C.P., Tauraso, N.M., Eddy, B. et al. Studies on inhibition of viral oncogenesis. Archiv f Virusforschung 36, 284–295 (1972). https://doi.org/10.1007/BF01249859
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01249859